ASICS is the reknowned footwear manufacturer that Japan relies on for the development of high-quality running shoes.
Rakuten's Shop of the Year award features the three best shops from 2015 out of over 40,000 shoplistings on Rakuten. Including vitamin E, almond called "Vitamin a rejuvenation that includes more than 10 different nutrients lacking in the diet of the modern, abundantly balanced dietary fiber, minerals and vitamins B, included in offers.
Is said that clear day in Japanese adult women, while vitamin e can be consumed approximately 8.7 mg in almond 23 grain (approximately 28 g) vitamin E intake guideline (approximately 8 mg). The almonds included a lot of insoluble plant fibers and fiber intestinal environment, may absorb excess lipids and toxins to control the action. Also helps to stabilize blood sugar levels after a meal to oleic acid diet and detoxification, you need almonds from the properties of the shape, well bite, bite and the texture of the Act itself greater satiety. Our products-what is exfoliation of almonds are mixed ones are somewhat over real or distorted, we hope if on-site so if Sir, quality doesn't matter I think.
Aegerion Pharmaceuticals is dedicated to the development and commercialization of novel therapies for patients with debilitating, often fatal, rare diseases. Aegerion enlisted Addison Whitney to develop a global trade name for its first product, a lomitapide asset. Juxtapid is indicated as an adjunct to a low-fat diet and other lipid-lowering treatments, including LDL apheresis where available, to reduce low-density lipoprotein cholesterol (LDL-C), total cholesterol (TC), apolipoprotein B (apo B) and non-high-density lipoprotein cholesterol (non-HDL-C) in patients with homozygous familial hypercholesterolemia. Addison Whitney is an expert in animal health branding across the farm and companion animal segments. Our animal health expertise isn't limited to just naming or just design; we have worked on projects across our verbal, visual, brand research and brand strategy teams. Notable work in the farm animal space includes Draxxin for cattle and pigs, Excede for dairy cattle, Fostera for pigs, Zolvix for sheep and Zylexis for horses.
Astellas approached us seeking a visually creative solution that would align its US corporate and employment brands.
Through this initial relationship, we have become Astellas’ branding partner of choice, particularly for its visual workflow.
AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of prescription medicines for gastrointestinal, cardiovascular, respiratory and inflammation, neuroscience, oncology and infectious diseases.
AstraZeneca developed a drug to prevent thrombotic events such as strokes or heart attacks in patients with acute coronary syndrome or myocardial infarction with ST elevation. Bayer HealthCare is known worldwide for its commitment to providing excellent healthcare solutions in areas such as research, consumer and pharmaceutical products and animal health. We also worked with Bayer R&I to develop a brand name for its informatics-driven, touch?screen hub that enables time savings and improved patient care. Two leading pharmaceutical companies, Pfizer and Bristol-Myers Squibb (BMS), developed a joint venture to create a drug that would aid in the prevention of venous thromboembolism and venous thromboembolic events. Accustomed to working with two different companies to create viable drug names, Addison Whitney jumped right in with both teams to develop a strong brand for the new drug. Bristol-Myers Squibb is a global BioPharma company firmly focused on its mission to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
At Pfizer, they apply science and global resources to bring therapies to people that extend and significantly improve their lives. Bristol-Myers Squibb (BMS) is a global BioPharma company firmly focused on its mission to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
Addison Whitney has had a relationship with BMS for more than a decade, and we've worked on a variety of projects, including brand name and name derivation development, device naming and brand research. Campbell Alliance, one of our sister companies, is an industry leader in biopharmaceutical and medical technology consulting. An element of the first project was a recruitment packet appealing to the college graduate. The brand identity work for Campbell Alliance stretched across our verbal, visual and brand strategy teams.
Celgene achieves medical progress that goes hand in hand with its promise to ensure all patients can benefit from the advancements.
Celgene partnered with Addison Whitney Health to create a global brand name for lenalidomide, its revolutionary drug. Since its launch, Revlimid has been approved to treat not only MDS, but also multiple myeloma, a cancer of the plasma cells in bone marrow. Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. Edwards requested Addison Whitney’s help to develop a naming strategy that would allow the organization to fully leverage its Intuity brand and provide a naming structure for future product naming. Eisai is a fully integrated pharmaceutical business with discovery, clinical, manufacturing and marketing capabilities. Addison Whitney Health led Eisai’s team through creative strategy workshops, brainstorm sessions and rounds of name and design options before deciding on the strongest candidates to move forward with in the trials. Forest Laboratories delivers pharmaceutical products that make a difference in people’s everyday lives.
Addison Whitney was commissioned by GE Healthcare to develop a brand name for its newest innovation in ultrasound technology.
Our creative team developed various name candidates for the ultrasound technology by evaluating current brand trends, determining unique features in each and identifying important brand qualities. We also advised on the approach to use descriptive terms to further differentiate the various versions, designed for specific procedures and diagnostics exams. Venue joins GE's other ultrasound brands: LOGIQ for general imaging, Vivid for cardiovascular imaging and Voluson for women's health and specialty imaging.
Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for more than 35 years.
Genentech partnered with Addison Whitney Health to create a global brand name for ado-trastuzumab emtansine or T-DM1. Kadcyla is the first antibody-drug conjugate for treating her2-positive metastatic breast cancer and is the fourth medicine from Genentech to receive FDA approval for people with advanced cancers within the past two years.

Gilead's portfolio of marketed products includes a number of category firsts, including the only complete treatment regimen for HIV infection available in a once-daily single pill. Addison Whitney developed the name Stribild for the medication, and it has since been approved by both the FDA and EMA. Gilead and GlaxoSmithKline (GSK) both improve the quality of human life by advancing the care of patients suffering from life-constraining diseases. Gilead and GSK developed ambrisentan, an endothelin receptor antagonist (ERA) used to treat pulmonary arterial hypertension (PAH), which causes high blood pressure in the lung arteries. Bristol-Myers Squibb (BMS) developed a fully human anti-program death (PD-1) antibody that was designed to re-activate the body’s immune system to destroy tumors rather than impacting the tumor cells directly, allowing unprecedented durable response and improved conditions.
Addison Whitney Health executed its unique, multi-step process in order to properly develop and test potential name candidates.
Brand name candidates were then tested via global linguistic evaluations, legal trademark prescreens, medical panel reviews, extensive pharmacist and physician safety testing and marketing research.
Sheridan Healthcare is an industry leader in providing clinical solutions to hospitals and outpatient centers, including aspects such as administrative support, staff recruiting and quality assurance. Addison Whitney partnered with Sheridan to help it find a more unified voice and identity to drive its business development and recruiting efforts, and to develop a strategic way to communicate this new position to both internal and external audiences.
We conducted a comprehensive, competitive brand audit, developed brand research and positioning concepts and created positioning guidelines and messaging. Shire has a simple purpose: to enable people with life-altering conditions to lead better lives. Addison Whitney worked with the Shire team to name its once-daily prescription medicine used to treat attention-deficit hyperactivity disorder (ADHD) in patients aged 6 to 17 years.
Addison Whitney was approached by Theratechnologies to develop a brand name for their new asset designed for a number of diseases, including HIV-lipodystrophy and growth hormone deficiency.
Global hearing healthcare company Unitron was looking for a partner to help make its product portfolio easier to understand for hearing professionals. To gather more insight and validate the nomenclature strategy options, we conducted focus groups with audiologists. Based on the research findings, we presented Unitron with a final recommendation for its brand architecture and portfolio nomenclature strategy.
With strategy options in place that better define the brand and help drive consistency, Unitron continues to develop innovative products for hearing professionals and their patients worldwide. Clinical trial branding provides an easy-to-remember, recognizable identity that helps to build awareness and commitment.
Upsher-Smith is an independent and privately owned specialty pharmaceutical company that focuses on product growth and innovation for branded and generic pharmaceuticals. For this particular project, Upsher-Smith asked us to develop a logo, color palette and PowerPoint template for two epilepsy treatment clinical trials.
It is designed for individuals who may need additional support in controlling their blood sugar levels. Mineral is a critical component in the metabolic and physiological function, essential for maintaining health because women tend to lack calcium and iron can be replenished easily. After going through our customized global name development process for Aegerion, we created the name Juxtapid. We have worked with Bayer Animal Health, Intervet, Merial, Novartis Animal Health and Pfizer Animal Health (Zoetis).
Notable work for companion animals includes Revolution for cats and dogs and Cerenia, Slentrol, Previcox and Certifect for dogs.
Astellas’ corporate communications and recruiting teams desired to bring the employment brand to life by borrowing concepts and inspiration from its corporate brand.
AstraZeneca operates in more than 100 countries, and its innovative medicines are used by millions of patients worldwide. Addison Whitney took the AstraZeneca team through our creative naming process and explored a number of naming options before landing on Brilinta as the new brand name. Addison Whitney has partnered with Bayer HealthCare for a variety of projects; a few highlights are below.
Our verbal branding team developed a set of updated branding options that effectively communicated the benefits of the product.
With the addition of the MEDRAD product group, Bayer R&I is able to provide its customers with service on existing Bayer products and on equipment manufactured by companies other than Bayer.
Along with the new brand strategy, we developed unique visual identities for the overall service group, its subgroups and the current product brands. Our verbal team developed the name Certegra to allude to a certainty and flexibility the system will provide to its users. After taking the teams through creative and strategic branding exercises, the name Eliquis was created. They strive to set the standard for quality, safety and value in the discovery, development and manufacture of healthcare products.
Our projects have spanned a variety of specialties, including anti-infectives, cardiology, metabolics, immunology, oncology, rheumatology and virology. Campbell Alliance approached Addison Whitney with two different projects: to design and develop its recruiting materials, and to create a new brand identity for its research and analytics subsidiary. We created a system of line illustrations that demonstrated the process from seed to fruit, representing the career path. We created a new name, Encuity, to replace Campbell Alliance Market Research and Analytics.
Improving the lives of patients is the ultimate goal, which is why Celgene developed an innovative drug to treat MDS, a malignant blood disease. Celgene has grown into one of the world’s largest biotechnology companies, thanks mostly to Revlimid, which has continued to gain market share since its launch. With a dedication to helping patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that enable them to save and enhance lives. We also went on to name a specialized technology that’s part of the new valve system and can be used with other systems.

Combined, major depressive disorder (MDD) and generalized anxiety disorder (GAD) affects more than 20 million adults in America in a given year. Since its introduction to the market, Lexapro has achieved substantial success and has been prescribed to more than 18 million US adults.
Once the brand name was decided, GE Healthcare's marketing team also tasked us with evaluating their current brand portfolio in the ultrasound market. The name extension strategy we developed was designed to guide GE's branding team on a clear strategy to differentiate the various brands, while avoiding overlap among target audiences.
GE Healthcare has gone on to utilize the Venue 40 sub-brand followed by five distinct descriptors: vascular access, anesthesia, interventional, musculoskeletal, and point of care. Genentech uses human genetic information to discover, develop, manufacture and commercialize medicines to treat patients with serious or life-threatening medical conditions. After going through a customized global name development process for Genentech, we created the name Kadcyla. Addison Whitney Health was approached to develop and test brand name candidates for the Anti-PD-1 asset. Addison Whitney Health conducted strategy and name development workshops to identify key characteristics to be applied to the creative process, such as highlighting the asset’s functional and emotional attributes and benefits.
Our research team conducted a brand assessment and employee survey and our design team designed and helped implement an internal visual campaign to display in Sheridan's corporate office.
Shire focuses on developing treatments for conditions where the impact of their medicines can make an immediate and tangible difference for patients.
Through creative branding sessions with the Shire team, we developed and tested the name INTUNIV for the new drug. It has proven to have fewer side effects to similar drugs on the market making it an attractive treatment for many.
The product established a new class of the once-daily GRF compounds, and with the related aspects served as a breakthrough innovation in the treatment of the diseases.
Additionally, Addison Whitney created and submitted name approval documents for Egrifta to the FDA, EMA, and Health Canada. With no clear strategy for future product naming, Addison Whitney was ready to take on the challenge. The focus groups allowed the participants to see potential nomenclature strategy options and provide direct feedback on whether the options were easy to understand or confusing. These new strategies will help hearing professionals better fit products to patients and provide a clear guide for future product naming. This type of branding can range from the name and logo, to messaging and marketing collateral. Upsher-Smith has a particular focus on developing therapies to assist people suffering from central nervous system diseases and also markets products relating to cardiology, dermatology, and women's health. Ultra Glucose Control delivers a ratio-balanced combination of carbohydrates, protein, and fat (40-30-30) to manage glucose response, consistent with recommendations from clinical centers.1,2 Formulated with MetaReleasea proprietary blend of slow-release, complex carbohydrates (UCAN SuperStarch) and fiberand high-quality proteins and branched-chain amino acids, Ultra Glucose Control supports a balanced glucose response and sustained energy release. And, as part of inVentiv Health, we are able to recommend other inVentiv resources that will seamlessly move your brand through development and into commercialization.
Our designers have created new visual identities for Astellas’ human resources brands, and updated PowerPoint slide templates and the full design development of its corporate magazine. We conducted a survey with key consumers within the target market, and the resulting research findings analysis allowed us to confidently recommend Wake-Up Call for the new brand.
Their global portfolio includes medicines and vaccines as well as many of the world’s best-known consumer healthcare products.
The overall design was a fresh and youthful translation of Campbell Alliance’s brand characteristics.
Encuity is derived from enabling acuity, or providing customers with sharpness in vision or thought to help them see the answers they need for their business. The names were derived from words associated with the trial and also conveyed confidence in the trial itself. To help make a difference, Forest Laboratories developed the next generation of Celexa, a selective serotonin reuptake inhibitor (SSRI) that treats depression and anxiety. Gilead strives to transform and simplify care for people with life-threatening illnesses around the world. Both names were deemed viable from regulatory bodies and have gone on to be successful drugs to treat PAH in patients. After obtaining regulatory approval, Opdivo entered the market and was subsequently named a "Brand of the Year" following its release.
Shire provides treatments in neuroscience, rare diseases, gastrointestinal, internal medicine and regenerative medicine.
Addison Whitney was one of the first firms to brand clinical trials in the pharmaceutical industry. UCAN SuperStarch contains more than 95% heat-moisture treated amylopectin, which is designed to digest slowly, leading to a sustained glucose and insulin response and prolonged satiety.
Our designers created a new logo, brand artwork, marketing materials, stationery and comprehensive style guide. The final identities for the clinical trials (left) are enclosed by a dynamic shape showing movement and flexibility. And our brand strategists developed messaging and consulted on positioning and nomenclature. Each identity uses a different orientation, but both show a positive and balanced look and feel.

Test yourself hypoglycemia
How to prevent blood sugar drops suddenly


  1. 17.11.2015 at 19:54:39

    And causes work to lower your blood sugar levels and avoid spikes.

    Author: milaya_ya
  2. 17.11.2015 at 15:40:46

    Ability to lower blood sugar shown that fenugreek can below 6.5, preferably below 6.0. Your blood.

    Author: login